Main
14 October 2019
New research by the Edwards group and collaborators shows that BMP inhibitors are able to reverse the main untreatable symptom of the disease.
The research, led by Dr Sarah Gooding, is an equal collaboration between the groups of Prof Hal Drakesmith at the MRC Human Immunology Unit (RDM) and the group of Prof Claire Edwards at NDORMS and the Nuffield Department of Surgical Sciences.
Read more (MRC Weatherall Institute of Molecular Medicine webiste)
Professor of Bone Oncology
Senior Postdoctoral Researcher
